About The Position

The Director Global Market Access & Pricing role for frexalimab contributes to pricing and market access strategy and execution across the RMS and nrSPMS indications. Frexalimab is a potential first-in-class anti-CD40L antibody, with a Phase 3 program underway. Multiple sclerosis is expected to be the first indication in a broader program spanning immunology and metabolic diseases, and strategic decisions made for MS may shape future indications. The role sits within the Global Market Access & Pricing Neurology Team in Specialty Care Global Market Access. It partners across Commercial, Medical, Clinical, Evidence for Access, Global Pricing, Biostatistics, Regulatory Affairs, Public Affairs, and country teams to support timely patient access and value recognition by external stakeholders, including payers. The position is based in Cambridge, Massachusetts.

Requirements

  • Bachelor’s degree minimum.
  • At least 7 years of pharmaceutical or biotech industry experience, with a track record in pricing and market access.
  • Experience working across different payer archetypes and deep knowledge of the US market and healthcare system.
  • Innovative mindset and ability to develop creative solutions to complex problems.
  • Track record developing and executing payer-shaping initiatives in challenging reimbursement environments.
  • Strong analytical skills, including pricing expertise, and ability to translate clinical information into clear payer access strategies and recommendations.
  • Flexibility and ability to manage multiple projects and priorities.
  • Relationship-building skills at all organizational levels and across geographies, with collaborative cross-functional experience.
  • Outstanding written and oral communication skills and ability to present complex information clearly and concisely.
  • Strong business acumen, analytical and financial skills to evaluate investment strategies; comfort with product forecasts and P&L.
  • Fluent written and spoken English.

Nice To Haves

  • Advanced degree.
  • Experience in multiple sclerosis, neurology, or similar complex therapeutic areas.

Responsibilities

  • Drive development of key pricing and market access deliverables, including the market access plan, payer value story, global pricing policy, contracting strategy, country launch sequencing, negotiation guide, and objection handler.
  • Collaborate with Commercial, Medical, Public Affairs, global business partners, and countries to shape the MS ecosystem and support payer value recognition of frexalimab by launch.
  • Generate actionable payer insights through primary research, payer advisory boards, and other platforms to pressure-test and refine the value proposition and ground strategies in market understanding.
  • Contribute to pricing and access strategy and scenario planning with Global Brand and Global Project Teams and country teams, taking a holistic approach to optimizing brand value.
  • Champion adoption of digital and AI-enabled tools in payer access strategy and execution, working with internal stakeholders to identify opportunities to enhance payer engagement, value messaging, and decision support.
  • Engage country teams and partner with country Market Access leads to co-develop global deliverables that support local payer negotiations.
  • Work with Evidence for Access, Medical, and relevant functions to secure evidence-generation plans, prioritization, and deliverables that support access and pricing objectives.
  • Maintain knowledge of MS and payer ecosystems, including scientific and clinical developments, competition, payer dynamics, and healthcare policy changes, to identify opportunities and threats and inform strategy.

Benefits

  • Health and wellbeing benefits, including high-quality healthcare and prevention and wellness programs.
  • At least 14 weeks of gender-neutral parental leave.
  • Company employee benefit programs; additional benefits information is available through the company.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service